ChemoTech expects to sign three new commercial contracts in fourth quarter-2023, in addition to the three already communicated, thereby pushing the previous stated target of 15 commercial contracts in India during fourth quarter-2023 to first quarter-2024. The reason for postponing the goal of 15 commercial installations in India to first quarter-2024 is linked to delays in negotiations as a result of the recent cyclone "Michaung" in the Chennai area. ChemoTech continues to make strong progress in discussions with Indian hospitals and the company's commercial and clinical teams have presented at three tumour board meetings with around 30 oncology experts during the last two months.

ChemoTech has also started discussions with leading cancer institutes in India which has translated in further evaluations of the TSE-technology with the explicit goal to make it part of the routine treatment protocol.